The role of vitamin D in male fertility: A focus on the testis

Reviews in Endocrine and Metabolic Disorders

Volumn 18, Issue 3, 2017, Pages 285-305

  de Angelis, Cristina ^a   Galdiero, Mariano ^a   Pivonello, Claudia ^b   Garifalos, Francesco ^b   Menafra, Davide ^b   Cariati, Federica ^b,c   Salzano, Ciro ^b   Galdiero, Giacomo ^b   Piscopo, Mariangela ^b   Vece, Alfonso ^b   Colao, Annamaria ^b   Pivonello, Rosario ^b  

^a IOS and COLEMAN Srl   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Environment; Hormone production; Lifestyle; Male fertility; Semen quality; Testis; Testosterone; Vitamin D

Indexed keywords

VITAMIN D; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

DRUG MECHANISM; HORMONE SYNTHESIS; HUMAN; MALE; MALE FERTILITY; MALE GENITAL SYSTEM; METABOLIC REGULATION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SPERM QUALITY; SYNTHESIS; TESTIS; TESTIS CANCER; TESTIS FUNCTION; VITAMIN D METABOLISM; ANIMAL; DRUG EFFECTS; FERTILITY; MALE INFERTILITY; PHYSIOLOGY; SEMEN ANALYSIS; SPERMATOGENESIS;

ANIMALS; FERTILITY; HUMANS; INFERTILITY, MALE; MALE; RECEPTORS, CALCITRIOL; SEMEN ANALYSIS; SPERMATOGENESIS; TESTIS; VITAMIN D;

EID: 85021727348     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-017-9425-0     Document Type: Review

References (153)

1. O'Donnell L, Stanton P, de Kretser DM. Endocrinology of the Male Reproductive System and Spermatogenesis. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM et al., editors. Endotext. South Dartmouth (MA)2000.
2. Mortimer D, Barratt CL, Bjorndahl L, de Jager C, Jequier AM, Muller CH. What should it take to describe a substance or product as 'sperm-safe'. Hum Reprod Update. 2013;19(Suppl 1):i1–45. doi:10.1093/humupd/dmt008.
3. Dusilova-Sulkova S. Vitamin D metabolism and vitamin D traditional and nontraditional, target organs: implications for kidney patients. J Ren Care. 2009;35(Suppl 1):39–44. doi:10.1111/j.1755-6686.2009.00066.x.
4. Savastano S, Barrea L, Savanelli MC, Nappi F, Di Somma C, Orio F, et al. Low vitamin D status and obesity: role of nutritionist. Rev Endocr Metab Disord. 2017; doi:10.1007/s11154-017-9410-7.
5. Nettore IC, Albano L, Ungaro P, Colao A, Macchia PE. Sunshine vitamin and thyroid. Rev Endocr Metab Disord. 2017; doi:10.1007/s11154-017-9406-3.
6. Altieri B, Muscogiuri G, Barrea L, Mathieu C, Vallone CV, Mascitelli L, et al. Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept. Rev Endocr Metab Disord. 2017; doi:10.1007/s11154-016-9405-9.
7. Altieri B, Grant WB, Casa SD, Orio F, Pontecorvi A, Colao A et al. Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer. Crit Rev Food Sci Nutr 2016:0. doi:10.1080/10408398.2015.1136922.
8. Muscogiuri G, Annweiler C, Duval G, Karras S, Tirabassi G, Salvio G, et al. Vitamin D and cardiovascular disease: from atherosclerosis to myocardial infarction and stroke. Int J Cardiol. 2017;230:577–84. doi:10.1016/j.ijcard.2016.12.053.
9. Focker M, Antel J, Ring S, Hahn D, Kanal O, Ozturk D, et al. Vitamin D and mental health in children and adolescents. Eur Child Adolesc Psychiatry. 2017; doi:10.1007/s00787-017-0949-3.
10. Muscogiuri G, Altieri B, de Angelis C, Palomba S, Pivonello R, Colao A, et al. Shedding new light on female fertility: the role of vitamin D. Rev Endocr Metab Disord. 2017; doi:10.1007/s11154-017-9407-2.
11. Tirabassi G, Cutini M, Muscogiuri G, Delli Muti N, Corona G, Galdiero M, et al. Association between vitamin D and sperm parameters: clinical evidence. Endocrine. 2016; doi:10.1007/s12020-016-1198-9.
12. Muscogiuri G, Altieri B, Annweiler C, Balercia G, Pal HB, Boucher BJ, et al. Vitamin D and chronic diseases: the current state of the art. Arch Toxicol. 2017;91(1):97–107. doi:10.1007/s00204-016-1804-x.
13. Haimi M, Kremer R. Vitamin D deficiency/insufficiency from childhood to adulthood: insights from a sunny country. World J Clin Pediat. 2017;6(1):1–9. doi:10.5409/wjcp.v6.i1.1.
14. Henry HL. Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab. 2011;25(4):531–41. doi:10.1016/j.beem.2011.05.003.
15. Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH)(2)vitamin D(3): genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011;25(4):543–59. doi:10.1016/j.beem.2011.05.010.
16. Blomberg JM. Vitamin D and male reproduction. Nat Rev Endocrinol. 2014;10(3):175–86. doi:10.1038/nrendo.2013.262.
17. Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS. Hewison M. Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol. 2014;144(Pt A):132–7. doi:10.1016/j.jsbmb.2013.09.012.
18. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999;96(4):507–15.
19. Veldurthy V, Wei R, Campbell M, Lupicki K, Dhawan P, Christakos S. 25-Hydroxyvitamin D(3) 24-hydroxylase: a key regulator of 1,25(OH)(2)D(3) catabolism and calcium homeostasis. Vitam Horm. 2016;100:137–50. doi:10.1016/bs.vh.2015.10.005.
20. Razzaque MS. The FGF23-klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol. 2009;5(11):611–9. doi:10.1038/nrendo.2009.196.
21. Brenza HL, DeLuca HF. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3. Arch Biochem Biophys. 2000;381(1):143–52. doi:10.1006/abbi.2000.1970.
22. Hu MC, Shiizaki K, Kuro-o M, Moe OW. Fibroblast growth factor 23 and klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol. 2013;75:503–33. doi:10.1146/annurev-physiol-030212-183727.
23. Fukumoto S. Phosphate metabolism and vitamin D. BoneKEy Rep. 2014;3:497. doi:10.1038/bonekey.2013.231.
24. Chen KS, DeLuca HF. Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta. 1995;1263(1):1–9.
25. DeLuca HF. The control of calcium and phosphorus metabolism by the vitamin D endocrine system. Ann N Y Acad Sci. 1980;355:1–17.
26. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C. Vitamin D: a pleiotropic hormone. Kidney Int. 2010;78(2):140–5. doi:10.1038/ki.2010.17.
27. Dawson MI, Xia Z. The retinoid X receptors and their ligands. Biochim Biophys Acta. 2012;1821(1):21–56. doi:10.1016/j.bbalip.2011.09.014.
28. Zanatta L, Zamoner A, Zanatta AP, Bouraima-Lelong H, Delalande C, Bois C, et al. Nongenomic and genomic effects of 1alpha,25(OH)2 vitamin D3 in rat testis. Life Sci. 2011;89(15–16):515–23. doi:10.1016/j.lfs.2011.04.008.
29. Nemere I, Yoshimoto Y, Norman AW. Calcium transport in perfused duodena from normal chicks: enhancement within fourteen minutes of exposure to 1,25-dihydroxyvitamin D3. Endocrinology. 1984;115(4):1476–83. doi:10.1210/endo-115-4-1476.
30. Norman AW, Bishop JE, Bula CM, Olivera CJ, Mizwicki MT, Zanello LP, et al. Molecular tools for study of genomic and rapid signal transduction responses initiated by 1 alpha,25(OH)(2)-vitamin D(3). Steroids. 2002;67(6):457–66.
31. Merke J, Kreusser W, Bier B, Ritz E. Demonstration and characterisation of a testicular receptor for 1,25-dihydroxycholecalciferol in the rat. Eur J Biochem / FEBS. 1983;130(2):303–8.
32. Zanatta L, Bouraima-Lelong H, Delalande C, Silva FR, Carreau S. Regulation of aromatase expression by 1alpha,25(OH)2 vitamin D3 in rat testicular cells. Reprod Fertil Dev. 2011;23(5):725–35. doi:10.1071/RD10163.
33. Zanatta L, Zamoner A, Goncalves R, Zanatta AP, Bouraima-Lelong H, Bois C, et al. Effect of 1alpha,25-dihydroxyvitamin D3 in plasma membrane targets in immature rat testis: ionic channels and gamma-glutamyl transpeptidase activity. Arch Biochem Biophys. 2011;515(1–2):46–53. doi:10.1016/j.abb.2011.09.001.
34. Zanatta L, Zamoner A, Goncalves R, Zanatta AP, Bouraima-Lelong H, Carreau S, et al. 1alpha,25-Dihydroxyvitamin D(3) signaling pathways on calcium uptake in 30-day-old rat Sertoli cells. Biochemistry. 2011;50(47):10284–92. doi:10.1021/bi201113n.
35. Walters MR. 1,25-dihydroxyvitamin D3 receptors in the seminiferous tubules of the rat testis increase at puberty. Endocrinology. 1984;114(6):2167–74. doi:10.1210/endo-114-6-2167.
36. Walters MR, Cuneo DL, Jamison AP. Possible significance of new target tissues for 1,25-dihydroxyvitamin D3. J Steroid Biochem. 1983;19(1C):913–20.
37. Akerstrom VL, Walters MR. Physiological effects of 1,25-dihydroxyvitamin D3 in TM4 Sertoli cell line. Am J Phys. 1992;262(6 Pt 1):E884–90.
38. Levy FO, Eikvar L, Jutte NH, Cervenka J, Yoganathan T, Hansson V. Appearance of the rat testicular receptor for calcitriol (1,25-dihydroxyvitamin D3) during development. J Steroid Biochem. 1985;23(1):51–6.
39. Levy FO, Eikvar L, Jutte NH, Froysa A, Tvermyr SM, Hansson V. Properties and compartmentalization of the testicular receptor for 1,25-dihydroxyvitamin D3. J Steroid Biochem. 1985;22(4):453–60.
40. Merke J, Hugel U, Ritz E. Nuclear testicular 1,25-dihydroxyvitamin D3 receptors in Sertoli cells and seminiferous tubules of adult rodents. Biochem Biophys Res Commun. 1985;127(1):303–9.
41. Schleicher G, Privette TH, Stumpf WE. Distribution of soltriol [1,25(OH)2-vitamin D3] binding sites in male sex organs of the mouse: an autoradiographic study. J Histochem Cytochem Off J Histochem Soc. 1989;37(7):1083–6.
42. Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D-3 receptor in rat reproductive tissues. Histochem Cell Biol. 1996;105(1):7–15. doi:10.1007/Bf01450873.
43. Majumdar SS, Bartke A, Stumpf WE. Vitamin D modulates the effects of follicle-stimulating hormone on Sertoli cell function and testicular growth in Siberian hamsters. Life Sci. 1994;55(19):1479–86.
44. Menegaz D, Barrientos-Duran A, Kline A, Silva FR, Norman AW, Mizwicki MT, et al. 1alpha,25(OH)2-vitamin D3 stimulation of secretion via chloride channel activation in Sertoli cells. J Steroid Biochem Mol Biol. 2010;119(3–5):127–34. doi:10.1016/j.jsbmb.2010.01.011.
45. Jensen MB, Lieben L, Nielsen JE, Willems A, Jorgensen A, Juul A, et al. Characterization of the testicular, epididymal and endocrine phenotypes in the Leuven Vdr-deficient mouse model: targeting estrogen signalling. Mol Cell Endocrinol. 2013;377(1–2):93–102. doi:10.1016/j.mce.2013.06.036.
46. Mahmoudi AR, Zarnani AH, Jeddi-Tehrani M, Katouzian L, Tavakoli M, Soltanghoraei H, et al. Distribution of vitamin D receptor and 1alpha-hydroxylase in male mouse reproductive tract. Reprod Sci. 2013;20(4):426–36. doi:10.1177/1933719112459235.
47. Rosso A, Pansera M, Zamoner A, Zanatta L, Bouraima-Lelong H, Carreau S, et al. 1alpha,25(OH)2-Vitamin D3 stimulates rapid plasma membrane calcium influx via MAPK activation in immature rat Sertoli cells. Biochimie. 2012;94(1):146–54. doi:10.1016/j.biochi.2011.10.001.
48. Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch Biochem Biophys. 2005;436(1):50–61. doi:10.1016/j.abb.2005.02.001.
49. Thomas K, Sung DY, Chen X, Thompson W, Chen YE, McCarrey J, et al. Developmental patterns of PPAR and RXR gene expression during spermatogenesis. Front Biosci. 2011;3:1209–20.
50. Dufour JM, Kim KH. Cellular and subcellular localization of six retinoid receptors in rat testis during postnatal development: identification of potential heterodimeric receptors. Biol Reprod. 1999;61(5):1300–8.
51. Gaemers IC, van Pelt AM, van der Saag PT, Hoogerbrugge JW, Themmen AP, de Rooij DG. Effect of retinoid status on the messenger ribonucleic acid expression of nuclear retinoid receptors alpha, beta, and gamma, and retinoid X receptors alpha, beta, and gamma in the mouse testis. Endocrinology. 1997;138(4):1544–51. doi:10.1210/endo.138.4.5051.
52. Vernet N, Dennefeld C, Rochette-Egly C, Oulad-Abdelghani M, Chambon P, Ghyselinck NB, et al. Retinoic acid metabolism and signaling pathways in the adult and developing mouse testis. Endocrinology. 2006;147(1):96–110. doi:10.1210/en.2005-0953.
53. Blomberg Jensen M, Nielsen JE, Jorgensen A, Rajpert-De Meyts E, Kristensen DM, Jorgensen N, et al. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod. 2010;25(5):1303–11. doi:10.1093/humrep/deq024.
54. Corbett ST, Hill O, Nangia AK. Vitamin D receptor found in human sperm. Urology. 2006;68(6):1345–9. doi:10.1016/j.urology.2006.09.011.
55. Aquila S, Guido C, Middea E, Perrotta I, Bruno R, Pellegrino M, et al. Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism. Reprod Biology Endocrinol. 2009;7:140. doi:10.1186/1477-7827-7-140.
56. Aquila S, Guido C, Perrotta I, Tripepi S, Nastro A, Ando S. Human sperm anatomy: ultrastructural localization of 1alpha,25-dihydroxyvitamin D receptor and its possible role in the human male gamete. J Anat. 2008;213(5):555–64. doi:10.1111/j.1469-7580.2008.00975.x.
57. Blomberg JM. Vitamin D metabolism, sex hormones, and male reproductive function. Reproduction. 2012;144(2):135–52. doi:10.1530/REP-12-0064.
58. Cariati F, Gigantino V, Coppola G, Pivonello C, Galdiero M, Botti G, Gandini L, Lenzi A, Franco R, Colao A, Pivonello R. Localization of VDR and RXR in germ cell testicular cancer. In: editor. MEDICINA DELLA RIPRODUZIONE TRA CLINICA E TECNOLOGIE. Padova, Italy: Cleup SC; 2013. p. 291–5.
59. Cariati F, Gigantino V, Coppola G, Pivonello C, Galdiero M, Botti G, Gandini L, Lenzi A, Franco R, Colao A, Pivonello R. Identification of vitamin D (VDR) and retinoic X (RXR) receptor in normal and neoplastic human reproductive tissues. Copenhagen: ECE; 2013.
60. Cariati F, Negri A, Pivonello C, Ferro M, Sarnataro M, Terracciano D, Galdiero M, Vitale P, Altieri V, Colao A, Pivonello R. Vitamin D in prostate cancer from genetic to clinics: Study of association between FoKI and TaqI vitamin D receptor polymorphisms and prostate cancer. In: Cleup SC, editor. RIPRODUZIONE E SESSUALITÀ: DALLA SPERIMENTAZIONE ALLA CLINICA. Padova, Italy: Cleup SC; 2012. p. 419–22.
61. Foresta C, Selice R, De Toni L, Di Mambro A, Carraro U, Plebani M, et al. Altered bone status in unilateral testicular cancer survivors: role of CYP2R1 and its luteinizing hormone-dependency. J Endocrinol Investig. 2013;36(6):379–84. doi:10.3275/8650.
62. Foresta C, Selice R, Di Mambro A, Strapazzon G. Testiculopathy and vitamin D insufficiency. Lancet. 2010;376(9749):1301. doi:10.1016/S0140-6736(10)61916-2.
63. Schepisi G, De Padova S, Scarpi E, Lolli C, Gurioli G, Menna C et al. Vitamin D status among long-term survivors of testicular cancer. Oncotarget. 2016. doi:10.18632/oncotarget.14167.
64. De Toni L, De Filippis V, Tescari S, Ferigo M, Ferlin A, Scattolini V, et al. Uncarboxylated osteocalcin stimulates 25-hydroxy vitamin D production in Leydig cell line through a GPRC6a-dependent pathway. Endocrinology. 2014;155(11):4266–74. doi:10.1210/en.2014-1283.
65. La Vignera S, Condorelli RA, Cimino L, Russo GI, Morgia G, Calogero AE. Late-onset hypogonadism: the advantages of treatment with human chorionic gonadotropin rather than testosterone. Aging male Off J Int Soc Study Aging Male. 2016;19(1):34–9. doi:10.3109/13685538.2015.1092021.
66. Foresta C, Strapazzon G, De Toni L, Perilli L, Di Mambro A, Muciaccia B, et al. Bone mineral density and testicular failure: evidence for a role of vitamin D 25-hydroxylase in human testis. J Clin Endocrinol Metab. 2011;96(4):E646–52. doi:10.1210/jc.2010-1628.
67. Chanakul A, Zhang MY, Louw A, Armbrecht HJ, Miller WL, Portale AA, et al. FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues. PLoS One. 2013;8(9):e72816. doi:10.1371/journal.pone.0072816.
68. Imai M, Ishikawa K, Matsukawa N, Kida I, Ohta J, Ikushima M, et al. Klotho protein activates the PKC pathway in the kidney and testis and suppresses 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression. Endocrine. 2004;25(3):229–34. doi:10.1385/ENDO:25:3:229.
69. Li SA, Watanabe M, Yamada H, Nagai A, Kinuta M, Takei K. Immunohistochemical localization of klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct Funct. 2004;29(4):91–9.
70. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444(7120):770–4. doi:10.1038/nature05315.
71. Martin A, David V, Quarles LD. Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev. 2012;92(1):131–55. doi:10.1152/physrev.00002.2011.
72. Steger K, Tetens F, Seitz J, Grothe C, Bergmann M. Localization of fibroblast growth factor 2 (FGF-2) protein and the receptors FGFR 1-4 in normal human seminiferous epithelium. Histochem Cell Biol. 1998;110(1):57–62.
73. Usdin TB, Paciga M, Riordan T, Kuo J, Parmelee A, Petukova G, et al. Tuberoinfundibular peptide of 39 residues is required for germ cell development. Endocrinology. 2008;149(9):4292–300. doi:10.1210/en.2008-0419.
74. Usdin TB, Bonner TI, Harta G, Mezey E. Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. Endocrinology. 1996;137(10):4285–97. doi:10.1210/endo.137.10.8828488.
75. Asa SL, Henderson J, Goltzman D, Drucker DJ. Parathyroid hormone-like peptide in normal and neoplastic human endocrine tissues. J Clin Endocrinol Metab. 1990;71(5):1112–8. doi:10.1210/jcem-71-5-1112.
76. Blomberg Jensen M, Lieben L, Nielsen JE, Willems A, Jorgensen A, Juul A, et al. Characterization of the testicular, epididymal and endocrine phenotypes in the Leuven Vdr-deficient mouse model: targeting estrogen signalling. Mol Cell Endocrinol. 2013;377(1–2):93–102. doi:10.1016/j.mce.2013.06.036.
77. Gensure RC, Antrobus SD, Fox J, Okwueze M, Talton SY, Walters MR. Homologous up-regulation of vitamin D receptors is tissue specific in the rat. J Bone Miner Res Off J Am Soc Bone Miner Res. 1998;13(3):454–63. doi:10.1359/jbmr.1998.13.3.454.
78. Blomberg Jensen M, Jorgensen A, Nielsen JE, Bjerrum PJ, Skalkam M, Petersen JH, et al. Expression of the vitamin D metabolizing enzyme CYP24A1 at the annulus of human spermatozoa may serve as a novel marker of semen quality. Int J Androl. 2012;35(4):499–510. doi:10.1111/j.1365-2605.2012.01256.x.
79. O'Shaughnessy PJ. Hormonal control of germ cell development and spermatogenesis. Semin Cell Dev Biol. 2014;29:55–65. doi:10.1016/j.semcdb.2014.02.010.
80. Khera M. Male hormones and men's quality of life. Curr Opin Urol. 2016;26(2):152–7. doi:10.1097/MOU.0000000000000256.
81. Ramaswamy S, Weinbauer GF. Endocrine control of spermatogenesis: role of FSH and LH/ testosterone. Spermatogenesis. 2014;4(2):e996025. doi:10.1080/21565562.2014.996025.
82. Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem. 1990;27(Pt 6):532–41. doi:10.1177/000456329002700603.
83. Schulster M, Bernie AM, Ramasamy R. The role of estradiol in male reproductive function. Asian J Androl. 2016;18(3):435–40. doi:10.4103/1008-682X.173932.
84. Iliadou PK, Tsametis C, Kaprara A, Papadimas I, Goulis DG. The Sertoli cell: Novel clinical potentiality. Hormones. 2015;14(4):14–504. doi:10.14310/horm.2002.1648.
85. Andersson AM, Petersen JH, Jorgensen N, Jensen TK, Skakkebaek NE. Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men. J Clin Endocrinol Metab. 2004;89(6):2873–9. doi:10.1210/jc.2003-032148.
86. Ivell R, Heng K, Anand-Ivell R. Insulin-like factor 3 and the HPG Axis in the male. Front Endocrinol. 2014;5:6. doi:10.3389/fendo.2014.00006.
87. Hayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley WF Jr. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab. 2000;85(9):3027–35. doi:10.1210/jcem.85.9.6795.
88. Sonnenberg J, Luine VN, Krey LC, Christakos S. 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology. 1986;118(4):1433–9. doi:10.1210/endo-118-4-1433.
89. Inpanbutr N, Reiswig JD, Bacon WL, Slemons RD, Iacopino AM. Effect of vitamin D on testicular CaBP28K expression and serum testosterone in chickens. Biol Reprod. 1996;54(1):242–8.
90. Kagi U, Chafouleas JG, Norman AW, Heizmann CW. Developmental appearance of the Ca2+−binding proteins parvalbumin, calbindin D-28K, S-100 proteins and calmodulin during testicular development in the rat. Cell Tissue Res. 1988;252(2):359–65.
91. Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE, et al. Endocrine regulation of male fertility by the skeleton. Cell. 2011;144(5):796–809. doi:10.1016/j.cell.2011.02.004.
92. Oury F, Ferron M, Huizhen W, Confavreux C, Xu L, Lacombe J, et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest. 2013;123(6):2421–33. doi:10.1172/JCI65952.
93. Pi M, Chen L, Huang MZ, Zhu W, Ringhofer B, Luo J, et al. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS One. 2008;3(12):e3858. doi:10.1371/journal.pone.0003858.
94. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology. 2000;141(4):1317–24. doi:10.1210/endo.141.4.7403.
95. Chin KY, Ima-Nirwana S, Wan Ngah WZ. Vitamin D is significantly associated with total testosterone and sex hormone-binding globulin in Malaysian men. Aging Male Off J Int Soc Study Aging Male. 2015;18(3):175–9. doi:10.3109/13685538.2015.1034686.
96. Valimaki VV, Alfthan H, Ivaska KK, Loyttyniemi E, Pettersson K, Stenman UH, et al. Serum estradiol, testosterone, and sex hormone-binding globulin as regulators of peak bone mass and bone turnover rate in young Finnish men. J Clin Endocrinol Metab. 2004;89(8):3785–9. doi:10.1210/jc.2003-032187.
97. Ramlau-Hansen CH, Moeller UK, Bonde JP, Olsen J, Thulstrup AM. Are serum levels of vitamin D associated with semen quality? Results from a cross-sectional study in young healthy men. Fertil Steril. 2011;95(3):1000–4. doi:10.1016/j.fertnstert.2010.11.002.
98. Hammoud AO, Meikle AW, Peterson CM, Stanford J, Gibson M, Carrell DT. Association of 25-hydroxy-vitamin D levels with semen and hormonal parameters. Asian J Androl. 2012;14(6):855–9. doi:10.1038/aja.2012.77.
99. Livshits G, Karasik D, Seibel MJ. Statistical genetic analysis of plasma levels of vitamin D: familial study. Ann Hum Genet. 1999;63(Pt 5):429–39.
100. Wulaningsih W, Van Hemelrijck M, Michaelsson K, Kanarek N, Nelson WG, Ix JH, et al. Association of serum inorganic phosphate with sex steroid hormones and vitamin D in a nationally representative sample of men. Androl. 2014;2(6):967–76. doi:10.1111/andr.285.
101. Ceglia L, Chiu GR, Harris SS, Araujo AB. Serum 25-hydroxyvitamin D concentration and physical function in adult men. Clin Endocrinol. 2011;74(3):370–6. doi:10.1111/j.1365-2265.2010.03926.x.
102. Anic GM, Albanes D, Rohrmann S, Kanarek N, Nelson WG, Bradwin G, et al. Association between serum 25-hydroxyvitamin D and serum sex steroid hormones among men in NHANES. Clin Endocrinol. 2016;85(2):258–66. doi:10.1111/cen.13062.
103. Blomberg Jensen M, Gerner Lawaetz J, Andersson AM, Petersen JH, Nordkap L, Bang AK, et al. Vitamin D deficiency and low ionized calcium are linked with semen quality and sex steroid levels in infertile men. Hum Reprod. 2016;31(8):1875–85. doi:10.1093/humrep/dew152.
104. Lerchbaum E, Pilz S, Trummer C, Rabe T, Schenk M, Heijboer AC, et al. Serum vitamin D levels and hypogonadism in men. Androl. 2014;2(5):748–54. doi:10.1111/j.2047-2927.2014.00247.x.
105. Wang N, Han B, Li Q, Chen Y, Chen Y, Xia F, et al. Vitamin D is associated with testosterone and hypogonadism in Chinese men: results from a cross-sectional SPECT-China study. Reprod Biol Endocrinol. 2015;13:74. doi:10.1186/s12958-015-0068-2.
106. Lee DM, Tajar A, Pye SR, Boonen S, Vanderschueren D, Bouillon R, et al. Association of hypogonadism with vitamin D status: the European male ageing study. Eur J Endocrinol. 2012;166(1):77–85. doi:10.1530/EJE-11-0743.
107. Chen RY, Nordin BE, Need AG, Scopacasa F, Wishart J, Morris HA, et al. Relationship between calcium absorption and plasma dehydroepiandrosterone sulphate (DHEAS) in healthy males. Clin Endocrinol. 2008;69(6):864–9. doi:10.1111/j.1365-2265.2008.03272.x.
108. Nimptsch K, Platz EA, Willett WC, Giovannucci E. Association between plasma 25-OH vitamin D and testosterone levels in men. Clin Endocrinol. 2012;77(1):106–12. doi:10.1111/j.1365-2265.2012.04332.x.
109. Wehr E, Pilz S, Boehm BO, Marz W, Obermayer-Pietsch B. Association of vitamin D status with serum androgen levels in men. Clin Endocrinol. 2010;73(2):243–8. doi:10.1111/j.1365-2265.2009.03777.x.
110. Tak YJ, Lee JG, Kim YJ, Park NC, Kim SS, Lee S, et al. Serum 25-hydroxyvitamin D levels and testosterone deficiency in middle-aged Korean men: a cross-sectional study. Asian J Androl. 2015;17(2):324–8. doi:10.4103/1008-682X.142137.
111. Rafiq R, van Schoor NM, Sohl E, Zillikens MC, Oosterwerff MM, Schaap L, et al. Associations of vitamin D status and vitamin D-related polymorphisms with sex hormones in older men. J Steroid Biochem Mol Biol. 2016;164:11–7. doi:10.1016/j.jsbmb.2015.11.013.
112. Heijboer AC, Oosterwerff M, Schroten NF, Eekhoff EM, Chel VG, de Boer RA, et al. Vitamin D supplementation and testosterone concentrations in male human subjects. Clin Endocrinol. 2015;83(1):105–10. doi:10.1111/cen.12711.
113. Zhao D, Ouyang P, de Boer IH, Lutsey PL, Farag YM, Guallar E, et al. Serum vitamin D and sex hormones levels in men and women: the multi-ethnic study of atherosclerosis (MESA). Maturitas. 2017;96:95–102. doi:10.1016/j.maturitas.2016.11.017.
114. Ferlin A, Selice R, Di Mambro A, Ghezzi M, Di Nisio A, Caretta N, et al. Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome. Osteoporos Int J Etablished Osteoporos Natl Osteoporos Found USA. 2015;26(8):2193–202. doi:10.1007/s00198-015-3136-8.
115. Gioia A, Ceccoli L, Ronconi V, Turchi F, Marcheggiani M, Boscaro M, et al. Vitamin D levels and bone mineral density: are LH levels involved in the pathogenesis of bone impairment in hypogonadal men? J Endocrinol Investig. 2014;37(12):1225–31. doi:10.1007/s40618-014-0187-1.
116. Meric C, Sonmez A, Aydogdu A, Tapan S, Haymana C, Basaran Y et al. Osteoprotegerin, fibroblast growth factor 23, and vitamin D3 levels in male patients with hypogonadism. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2014;46(13):955–8. doi:10.1055/s-0034-1387789.
117. Hochberg Z, Borochowitz Z, Benderli A, Vardi P, Oren S, Spirer Z, et al. Does 1,25-dihydroxyvitamin D participate in the regulation of hormone release from endocrine glands? J Clin Endocrinol Metab. 1985;60(1):57–61. doi:10.1210/jcem-60-1-57.
118. Zofkova I, Scholz G, Starka L. Effect of calcitonin and 1,25(OH)2-vitamin D3 on the FSH, LH and testosterone secretion at rest and LHRH stimulated secretion. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 1989;21(12):682–5.
119. Foresta C, Calogero AE, Lombardo F, Lenzi A, Ferlin A. Late-onset hypogonadism: beyond testosterone. Asian J Androl. 2015;17(2):236–8. doi:10.4103/1008-682X.135985.
120. Canguven O, Talib RA, El Ansari W, Yassin DJ, Al NA. Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men. Aging Male Off J Int Soc Study Aging Male. 2017:1–8. doi:10.1080/13685538.2016.1271783.
121. Jorde R, Grimnes G, Hutchinson MS, Kjaergaard M, Kamycheva E, Svartberg J. Supplementation with vitamin D does not increase serum testosterone levels in healthy males. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.2013;45(9):675–81. doi:10.1055/s-0033-1345139.
122. Pilz S, Frisch S, Koertke H, Kuhn J, Dreier J, Obermayer-Pietsch B et al. Effect of vitamin D supplementation on testosterone levels in men. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2011;43(3):223–5. doi:10.1055/s-0030-1269854.
123. Haymana C, Sonmez A, Aydogdu A, Tapan S, Basaran Y, Meric C, et al. Effect of testosterone replacement therapy on vitamin D and FGF-23 levels in congenital hypogonadism. Endokrynologia Polska. 2017; doi:10.5603/EP.a2017.0009.
124. Tirabassi G. Delli Muti N, Gioia a, Biagioli a, Lenzi a, Balercia G. Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism. J Endocrinol Investig. 2014;37(4):393–400. doi:10.1007/s40618-014-0052-2.
125. Dabaja AA, Bryson CF, Schlegel PN, Paduch DA. The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density. BJU Int. 2015;115(3):480–5. doi:10.1111/bju.12870.
126. Francis RM, Peacock M, Aaron JE, Selby PL, Taylor GA, Thompson J, et al. Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone. 1986;7(4):261–8.
127. Hagenfeldt Y, Linde K, Sjoberg HE, Zumkeller W, Arver S. Testosterone increases serum 1,25-dihydroxyvitamin D and insulin-like growth factor-I in hypogonadal men. Int J Androl. 1992;15(2):93–102.
128. Hofer D, Munzker J, Schwetz V, Ulbing M, Hutz K, Stiegler P, et al. Testicular synthesis and vitamin D action. J Clin Endocrinol Metab. 2014;99(10):3766–73. doi:10.1210/jc.2014-1690.
129. Krishnan AV, Swami S, Peng L, Wang J, Moreno J, Feldman D. Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology. 2010;151(1):32–42. doi:10.1210/en.2009-0855.
130. Lundqvist J, Norlin M, Wikvall K. 1alpha,25-Dihydroxyvitamin D3 exerts tissue-specific effects on estrogen and androgen metabolism. Biochim Biophys Acta. 2011;1811(4):263–70. doi:10.1016/j.bbalip.2011.01.004.
131. Dennis NA, Houghton LA, Jones GT, van Rij AM, Morgan K, McLennan IS. The level of serum anti-Mullerian hormone correlates with vitamin D status in men and women but not in boys. J Clin Endocrinol Metab. 2012;97(7):2450–5. doi:10.1210/jc.2012-1213.
132. Malloy PJ, Peng L, Wang J, Feldman D. Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells. Endocrinology. 2009;150(4):1580–7. doi:10.1210/en.2008-1555.
133. Kwiecinski GG, Petrie GI, DeLuca HF. Vitamin D is necessary for reproductive functions of the male rat. J Nutr. 1989;119(5):741–4.
134. Uhland AM, Kwiecinski GG, DeLuca HF. Normalization of serum calcium restores fertility in vitamin D-deficient male rats. J Nutr. 1992;122(6):1338–44.
135. Sood S, Marya RK, Reghunandanan R, Singh GP, Jaswal TS, Gopinathan K. Effect of vitamin D deficiency on testicular function in the rat. Ann Nutr Metab. 1992;36(4):203–8.
136. Sood S, Reghunandanan R, Reghunandanan V, Marya RK, Singh PI. Effect of vitamin D repletion on testicular function in vitamin D-deficient rats. Ann Nutr Metab. 1995;39(2):95–8.
137. Sun W, Chen L, Zhang W, Wang R, Goltzman D, Miao D. Active vitamin D deficiency mediated by extracellular calcium and phosphorus results in male infertility in young mice. Am J Physiol Endocrinol Metab. 2015;308(1):E51–62. doi:10.1152/ajpendo.00076.2014.
138. Rojansky N, Brzezinski A, Schenker JG. Seasonality in human reproduction: an update. Hum Reprod. 1992;7(6):735–45.
139. Tartagni M, Matteo M, Baldini D, Tartagni MV, Alrasheed H, De Salvia MA, et al. Males with low serum levels of vitamin D have lower pregnancy rates when ovulation induction and timed intercourse are used as a treatment for infertile couples: results from a pilot study. Reprod Biol Endocrinol. 2015;13:127. doi:10.1186/s12958-015-0126-9.
140. Blomberg Jensen M, Bjerrum PJ, Jessen TE, Nielsen JE, Joensen UN, Olesen IA, et al. Vitamin D is positively associated with sperm motility and increases intracellular calcium in human spermatozoa. Hum Reprod. 2011;26(6):1307–17. doi:10.1093/humrep/der059.
141. Yang B, Sun H, Wan Y, Wang H, Qin W, Yang L, et al. Associations between testosterone, bone mineral density, vitamin D and semen quality in fertile and infertile Chinese men. Int J Androl. 2012;35(6):783–92. doi:10.1111/j.1365-2605.2012.01287.x.
142. Zhu CL, Xu QF, Li SX, Wei YC, Zhu GC, Yang C, et al. Investigation of serum vitamin D levels in Chinese infertile men. Andrologia. 2016;48(10):1261–6. doi:10.1111/and.12570.
143. Abbasihormozi S, Kouhkan A, Alizadeh AR, Shahverdi AH, Nasr-Esfahani MH, Sadighi Gilani MA, et al. Association of vitamin D status with semen quality and reproductive hormones in Iranian subfertile men. Androl. 2016; doi:10.1111/andr.12280.
144. Deng XL, Li YM, Yang XY, Huang JR, Guo SL, Song LM. [efficacy and safety of vitamin D in the treatment of idiopathic oligoasthenozoospermia]. Zhonghua nan ke xue =. Natl J Androl. 2014;20(12):1082–5.
145. Blomberg Jensen M, Dissing S. Non-genomic effects of vitamin D in human spermatozoa. Steroids. 2012;77(10):903–9. doi:10.1016/j.steroids.2012.02.020.
146. Ma Y, Johnson CS, Trump DL. Mechanistic insights of vitamin D anticancer effects. Vitam Horm. 2016;100:395–431. doi:10.1016/bs.vh.2015.11.003.
147. Sonne SB, Almstrup K, Dalgaard M, Juncker AS, Edsgard D, Ruban L, et al. Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res. 2009;69(12):5241–50. doi:10.1158/0008-5472.CAN-08-4554.
148. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of Tumours of the urinary system and male genital organs-part a: renal, penile, and testicular Tumours. Eur Urol. 2016;70(1):93–105. doi:10.1016/j.eururo.2016.02.029.
149. Blomberg Jensen M, Jorgensen A, Nielsen JE, Steinmeyer A, Leffers H, Juul A, et al. Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo. Neoplasia. 2012;14(10):952–63.
150. Bremmer F, Thelen P, Pottek T, Behnes CL, Radzun HJ, Schweyer S. Expression and function of the vitamin D receptor in malignant germ cell tumour of the testis. Anticancer Res. 2012;32(1):341–9.
151. Jorgensen A, Blomberg Jensen M, Nielsen JE, Juul A, Rajpert-De ME. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model. J Steroid Biochem Mol Biol. 2013;136:238–46. doi:10.1016/j.jsbmb.2012.10.008.
152. Koster R, di Pietro A, Timmer-Bosscha H, Gibcus JH, van den Berg A, Suurmeijer AJ, et al. Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer. J Clin Invest. 2010;120(10):3594–605. doi:10.1172/JCI41939.
153. Saramaki A, Banwell CM, Campbell MJ, Carlberg C. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res. 2006;34(2):543–54. doi:10.1093/nar/gkj460.